Adrian Ibrahim

Founder

Inaugural Chair, UK BIA Genomics Advisory Committee
20+ years’ experience of technology development & commercialisation in cancer and genomics
Genomics company spin outs include: Microbiotica, Congenica, 14M Genomics
Genomics industry transactions include Open Targets, a £200m+ multi pharma genomic target discovery initiative.

Mathew Garnett